Key points are not available for this paper at this time.
Design
Editorial
No takes yet. Share an insight, caveat, or question.
The authors agree that drug-calibrated specific assays would be beneficial for monitoring argatroban therapy, though access is limited in some regions, and further studies are needed to finalize the therapeutic range.
Roberts et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: